GALECTIN THERAPEUTICS INC (GALT) insider buying and selling

NASDAQ: GALT · Source: SEC Form 4 filings · Latest trade reported

There were no open-market insider purchases or sales at GALECTIN THERAPEUTICS INC (GALT) in the last 90 days. Over the last 12 months, 2 insiders sold $522K, of which $522K was scheduled or tax-related.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
0
$0 · 0 insiders
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
8
$522K · 2 insiders

This is the public summary. Create a free account to see GALT’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock GALT

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

No discretionary open-market insider trades were reported in the last 12 months.

Scheduled and tax-related sales

Sales made under a pre-arranged 10b5-1 plan or to cover tax on vesting shares. They are listed separately because they are not a fresh decision to sell.

Scheduled and tax-related insider sales at GALECTIN THERAPEUTICS INC
DateInsiderTypeSharesPriceValue
Khurram Jamil
Chief Medical Officer
10b5-1 sale16,250$5.13$83K
Khurram Jamil
Chief Medical Officer
10b5-1 sale
4 trades
59,594avg. $4.80$286K
Harold H. Shlevin
Director
10b5-1 sale
2 trades
30,000avg. $5.03$151K
Khurram Jamil
Chief Medical Officer
10b5-1 sale568$3.10$2K

What the GALT insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for GALECTIN THERAPEUTICS INC and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with GALT Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about GALT insider trading

Who bought GALECTIN THERAPEUTICS INC (GALT) stock recently?

No insider made an open-market purchase of GALECTIN THERAPEUTICS INC (GALT) stock in the last 12 months.

Are insiders buying or selling GALT?

Insiders made no discretionary trades in GALT over the last 12 months; the only sales were scheduled or tax-related.

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see GALT in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.